Navigation Links
State-of-the-art electron microscope promises to aid major research advances
Date:3/9/2009

rkings of nanotechnology happen."

Such new capabilities "will enhance existing research and teaching at ASU, and lead to exciting new research on catalyst nanoparticles for energy production, batteries for hybrid vehicles, materials for direct-conversion solar cells and interfaces in multiphase nanocomposites," Carpenter said.

The new microscope also will have several striking educational functions, he said. Because it is a digital instrument, unlike most earlier analog microscopes, images and spectroscopy experiments can be transmitted over the Internet in real time, with a voice track to describe the observations to a properly equipped classroom, for students of any age.

"We will be able to make DVD recordings or web pages of various experiments for viewing by K-12 teachers and students as many times as they wish for class study," Carpenter said. "They will be able to observe structures and atom movements as they occur in real solids. With a computer and digital projector, we can go anywhere in the world to help teach classes that illustrate behavior of materials at the atomic level using real research results."

"The higher resolution results that will be available from aberration-corrected microscopes will be even more useful for introducing young students and their teachers to the world of engineering and nanoscience," Carpenter said.


'/>"/>

Contact: Joe Kullman
joe.kullman@asu.edu
480-965-8122
Arizona State University
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Home Delivery Medical Offers New Glucose Meter With State-Of-The-Art Technology
2. Swedish in Seattle Unveils State-of-the-Art Brain Tumor Center Combining Advanced Treatment With Innovation in Research
3. Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis
4. SAFC Hitech(TM) Expands Sheboygan Facility With State-of-the-Art Manufacturing Cleanroom
5. Medical University of South Carolina Opens State-of-the-Art Facility
6. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
7. Researchers discover a potential on-off switch for nanoelectronics
8. Latest issue of Science: Nanosonar uses electrons to measure under the surface
9. MIT uses nano-origami to build tiny electronic devices
10. Latest issue of Science: Nano-sonar uses electrons to measure under the surface
11. Scientists prove graphenes edge structure affects electronic properties
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 30, 2015 Oxford Finance LLC ("Oxford"), a ... sciences and healthcare services companies, today announced the closing ... with Celula, Inc., a diagnostic testing company focused on ... patient care and improved outcomes.  Proceeds of the loan ... the commercialization of its products in the U.S. and ...
(Date:4/30/2015)... April 30, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that it will release ... 7, 2015 after the close of the U.S. financial ... webcast on Thursday, May 7, 2015 at 4:30 p.m. ... and recent corporate developments. For both "listen-only" ...
(Date:4/30/2015)... SureClinical, a leader in cloud-based health ... joined SureClinical’s executive team as Chief Financial Officer. ... executive with over 25 years in leadership roles ranging ... Ms. Morris joins SureClinical from Marrone Bio Innovations (MBI), ... of MBI from its founding in 2006 until 2011, ...
(Date:4/29/2015)... (TSX-V: BRM) ("Biorem" or "the Company") today announced its results for the ... year-end financial statements and MD&A have been filed on SEDAR ( www.sedar.com ... 2014 , 2013 Revenue 3,968 , 5,121 ... , 1,703 , 2,231 , 5,866 Operating  ... , 4,562 Ebitda* 92 , 418 , ...
Breaking Biology Technology:Oxford Finance Provides $10 Million Debt Financing to Celula 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 3Julie I. Morris Joins SureClinical as Chief Financial Officer 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4
... EXTON, Pa., Feb. 28, 2012 ViroPharma Incorporated (Nasdaq: ... fourth quarter and year ended December 31, 2011. ... in annual net product sales, including $251 million in net ... in net sales of Vancocin® (Vancomycin Hydrochloride Capsules, USP); ...
... NOVATO, Calif., Feb. 28, 2012 Ultragenyx Pharmaceutical ... for rare and ultra-rare genetic disorders, today announced ... has granted orphan drug designation for UX003 for ... an extremely rare autosomal recessive lysosomal storage disorder ...
... Verenium Corporation (Nasdaq: VRNM ), a leading ... high-performance enzymes, today announced that it will release ... 5, 2012 at 8:00 a.m. ET. In conjunction with the ... webcast on Monday, March 5 at 8:30 a.m. ET. ...
Cached Biology Technology:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 3ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 4ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 5ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 6ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 7ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 8ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 9ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 10ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 11ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results 12Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7) 2Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7) 3Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results 2Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results 3
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and Markets ... "Face and Voice Biometrics - Global Strategic Business Report" report ... for Face and Voice Biometrics in US$ Thousands by the following ... analytics for the US, Canada , ... , Middle East & ...
(Date:3/23/2015)... -- SoundView Technology Group issues a new research update following ... smart wallet. SoundView was one of the selected user groups to ... Wocket in multiple scenarios and outlets. Soundview ... making both debit and credit card payments.  ... company meets their plans in 2015, it would push our ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
... of Appeals has overturned an August 2010 ban on federal ... broader exploration of how stem cells function and how they ... incurable diseases. The ruling has been welcomed by the ... and by the nation,s top researchers in the field, including ...
... 27, 2011 According to the Centers for Disease Control ... more likely to die from diabetes than someone living in ... parts of the United States. Now, a group of seven ... change those health disparities and improve health through the creation ...
... A gene therapy approach using a protein called ... of age-related macular degeneration (AMD), according to a new ... of Medicine. Led by senior author Rajendra Kumar-Singh, PhD, ... delivered by a gene therapy approach significantly reduced the ...
Cached Biology News:US Appeals Court opens federal funding for stem cell research 2Network created to address obesity, chronic health issues in Appalachian region 2Network created to address obesity, chronic health issues in Appalachian region 3Gene therapy shows promise against age-related macular degeneration 2
6X DNA Gel Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
Xanthine Oxidase (Bovine Buttermilk). Monospecific by IEP. Some cross reactivity with Xanthine Oxidase of other species and tissues may occur....
...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Biology Products: